Profiel
Eric Rojas is currently the Vice President of Investor Relations at Stoke Therapeutics, Inc. He previously worked as a Senior Director of Investor Relations at Shire Plc.
Actieve functies van Eric Rojas
| Bedrijven | Functie | Begin |
|---|---|---|
| STOKE THERAPEUTICS, INC. | Investor Relations Contact | - |
Eerdere bekende functies van Eric Rojas
| Bedrijven | Functie | Einde |
|---|---|---|
| SHIRE | Investor Relations Contact | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| STOKE THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
